Concepedia

Author

Joycelyn Entwistle

Viventia Bio (Canada)

Also Known As

Joycelyn Entwistle

24

Publications

1.1K

Citations

12

H-Index

45

Concepts

All Affiliations

Viventia Bio (Canada)University of ManitobaCarlsberg Laboratory
JE

About

Joycelyn Entwistle is an author at Viventia Bio (Canada) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

373

2

Natural Sciences

2

2

102

3

Engineering

1

1

16

4

Allergy

1

1

16

5

Biology

1

1

47

Joycelyn Entwistle

×

11

Publications

557

Citations

11

H-Index

YearCitations

A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin

Mark Kowalski, Jacinthe Guindon, Louise Brazas,

The Journal of Urology

2012

115

Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin

Jeannick Cizeau, Danielle M. Grenkow, Jennifer G. Brown,

Journal of Immunotherapy

2009

79

Characterization of the murine gene encoding the hyaluronan receptor RHAMM

Joycelyn Entwistle, Shiwen Zhang, Baihua Yang,

Gene

1995

68

The characterization of a human RHAMM cDNA: conservation of the hyaluronan-binding domains

Chao Wang, Joycelyn Entwistle, Guangpei Hou,

Gene

1996

67

Primary structure of a C-hordein gene from barley

Joycelyn Entwistle

Carlsberg Research Communications

1988

55

Amber codon suppression: the in vivo and in vitro analysis of two C-hordein genes from barley

Joycelyn Entwistle, S�ren Knudsen, Martin M�ller,

Plant Molecular Biology

1991

47

Transforming Growth Factor-β1 Stimulates Multiple Protein Interactions at a Unique -Element in the 3′-Untranslated Region of the Hyaluronan Receptor RHAMM mRNA

Francis Amara, Joycelyn Entwistle, Theodore I. Kuschak,

Journal of Biological Chemistry

1996

44

Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential

Joycelyn Entwistle, Jennifer G. Brown, Shilpa Chooniedass,

Cancer Biotherapy and Radiopharmaceuticals

2012

25

Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance

Rachelle L. Dillon, Shilpa Chooniedass, Arjune Premsukh,

Journal of Immunotherapy

2016

25

Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration

Jennifer G. Brown, Michèle Rasamoelisolo, Maureen Spearman,

Cancer Biotherapy and Radiopharmaceuticals

2009

16

Page 1